Multi-organ protective role of ellagic acid-selenium nanoparticles against cyclophosphamide-mediated oxidative damage: biochemical and histological insights
Journal of Pharmacy and Pharmacology · 04.11.2026 · 78 (11)
DOI: 10.1093/jpp/rgag133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 10.11.2026. Verfasst von Asim Amitabh Sahu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology and Pharmacology Laboratory, Department of Zoology, Guru Ghasidas University, Koni-Bilaspur, Chhattisgarh 495009, India. Hauptthemen laut MEDLINE: Cyclophosphamide, Ellagic Acid, Oxidative Stress, Antioxidants. Die Arbeit nennt 83 Literaturangaben. Gefördert von: Department of Biotechnology, Government of India, University Grants Commission, Government of India, Department of Science and Technology, Government of India.
Abstract (Originalsprache)
Objectives
Cyclophosphamide induces severe oxidative stress-mediated multi-organ toxicity, limiting its therapeutic application. The present study evaluated the protective effects of ellagic acid-selenium nanoparticles against cyclophosphamide-induced injury to liver, kidney, and brain.
Methods
Male Wistar rats were pretreated orally with ellagic acid-selenium nanoparticles at doses of 1, 2, 3, and 4 mg/kg for six consecutive days followed by a single intraperitoneal administration of cyclophosphamide at 200 mg/kg on Day 6. Body and organ weights, oxidative stress markers, antioxidant enzymes, microsomal enzyme activity, biochemical and neurochemical parameters, and histopathological alterations were assessed. Key findings Cyclophosphamide exposure markedly increased lipid peroxidation and significantly reduced glutathione, superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, and glucose-6-phosphate dehydrogenase activities. Altered microsomal enzyme activity, elevated liver and kidney function markers, dyslipidaemia, increased acetylcholinesterase and butyrylcholinesterase activities, reduction in body weight, altered relative organ weights, and severe histopathological damage in liver, kidney, and brain tissues were also observed. Pretreatment with ellagic acid-selenium nanoparticles significantly restored antioxidant defence systems, normalized biochemical and neurochemical alterations, and preserved tissue architecture in a dose-dependent manner.
Conclusions
Ellagic acid-selenium nanoparticles demonstrated substantial multi-organ protective effects against cyclophosphamide-induced oxidative injury and may represent a promising adjunctive nanomedicine strategy for reducing chemotherapy-associated systemic toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toxicology and Pharmacology Laboratory, Department of Zoology, Guru Ghasidas University, Koni-Bilaspur, Chhattisgarh 495009, India.
- Laboratory of Natural Products, Department of Rural Technology and Social Development, Guru Ghasidas University, Koni-Bilaspur, Chhattisgarh 495009, India.
ORCID-Profile: Asim Amitabh Sahu, Satendra Kumar Nirala, Monika Bhadauria
Förderung
- Department of Biotechnology, Government of India
- University Grants Commission, Government of India
- Department of Science and Technology, Government of India
- Guru Ghasidas Vishwavidyalaya
Zitieren
APA
Sahu, A. A., Nirala, S. K., & Bhadauria, M. (2026). Multi-organ protective role of ellagic acid-selenium nanoparticles against cyclophosphamide-mediated oxidative damage: biochemical and histological insights. Journal of Pharmacy and Pharmacology, 78(11). https://doi.org/10.1093/jpp/rgag133
Vancouver
Sahu AA, Nirala SK, Bhadauria M. Multi-organ protective role of ellagic acid-selenium nanoparticles against cyclophosphamide-mediated oxidative damage: biochemical and histological insights. Journal of Pharmacy and Pharmacology. 2026;78(11). doi:10.1093/jpp/rgag133
BibTeX
@article{Sahu2026,
author = {Sahu, Asim Amitabh and Nirala, Satendra Kumar and Bhadauria, Monika},
title = {Multi-organ protective role of ellagic acid-selenium nanoparticles against cyclophosphamide-mediated oxidative damage: biochemical and histological insights},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {11},
doi = {10.1093/jpp/rgag133}
}
EUVIMED